New blood test may spot kidney damage sooner after dye procedures

NCT ID NCT07197957

Recruiting now Diagnosis Sponsor: BayCare Health System Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at whether a blood test for cystatin C can detect acute kidney injury earlier than the standard test in people with chronic kidney disease who receive contrast dye for CT scans or heart procedures. Researchers will compare how often kidney injury is found using each test in 100 adult inpatients. The goal is to see if cystatin C provides a faster warning, allowing doctors to act sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cystatin C blood test
What this could lead to: If successful, this could lead to faster and more accurate detection of kidney injury after contrast dye procedures, potentially preventing serious kidney damage.
What could go wrong: This is a small, early-stage study with only 100 participants, so results may not apply to everyone. The test may not prove significantly better than current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury chronic kidney disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY INJURY

Contacts and locations

Locations

Mease Countryside Hospital
RECRUITING

Safety Harbor, Florida, 34695, United States
Morton Plant Hospital
RECRUITING

Clearwater, Florida, 33756, United States
Morton Plant North Bay Hospital
RECRUITING

New Port Richey, Florida, 34652, United States
St. Anthony's Hospital
RECRUITING

St. Petersburg, Florida, 33705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.